Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies
Vishnu Nayak Badavath, Akhil Kumar, Pralok K. Samanta, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 3110-3128
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints
Mithun Rudrapal, Kevser Kübra Kırboğa, Mohnad Abdalla, et al.
Molecular Diversity (2024) Vol. 28, Iss. 4, pp. 2099-2118
Closed Access | Times Cited: 22
Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
Suresh Gangadevi, Vishnu Nayak Badavath, Abhishek Thakur, et al.
The Journal of Physical Chemistry Letters (2021) Vol. 12, Iss. 7, pp. 1793-1802
Closed Access | Times Cited: 92
Isatin derivatives as broad-spectrum antiviral agents: the current landscape
Tilal Elsaman, Malik Suliman Mohamed, Eyman Mohamed Eltayib, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 2, pp. 244-273
Open Access | Times Cited: 52
A survey of isatin hybrids and their biological properties
Vanessa Asoh Shu, Donatus Bekindaka Eni, Fidele Ntie‐Kang
Molecular Diversity (2024)
Open Access | Times Cited: 10
Synthesis, Structural Characterization, DFT Calculations, and Molecular Docking of a Novel Quinoline Derivative
Asif Jamal, Md. Serajul Haque Faizi, Necmi Dege
Journal of Molecular Structure (2023) Vol. 1300, pp. 137251-137251
Closed Access | Times Cited: 18
Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket
Chia‐Ying Huang, A. Metz, Roland Lange, et al.
Acta Crystallographica Section D Structural Biology (2024) Vol. 80, Iss. 2, pp. 123-136
Open Access | Times Cited: 6
Natural and Nature-Derived Products Targeting Human Coronaviruses
Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 448-448
Open Access | Times Cited: 34
Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2
Vishal Singh, Himani Chaurasia, Priyanka Kumari, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 21, pp. 10519-10542
Open Access | Times Cited: 33
Therapeutical Potential of Imines; Synthesis, Single Crystal Structure, Computational, Molecular Modeling, and ADMET Evaluation
Diğdem Tatlιdil, Muhammad Asam Raza, Necmi Dege, et al.
ACS Omega (2022) Vol. 7, Iss. 12, pp. 10568-10579
Open Access | Times Cited: 25
Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
Mohamed Fizur Nagoor Meeran, A. Seenipandi, Hayate Javed, et al.
Heliyon (2020) Vol. 7, Iss. 1, pp. e05703-e05703
Open Access | Times Cited: 36
Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes
Hakan Alıcı, Hakan Tahtacı, Kadir Demır
Computational Biology and Chemistry (2022) Vol. 98, pp. 107657-107657
Open Access | Times Cited: 19
Hydration effects on molecular structure, vibrational, electronic properties, drug-likeness analysis, molecular docking, and molecular dynamics studies of (Z)-3-(2-oxo-2-phenylethylidene)indolin-2-one
Stève–Jonathan Koyambo-Konzapa, Samar O. Aljazzar, Gilbert Yvon Mbesse Kongbonga, et al.
Journal of Molecular Liquids (2024) Vol. 410, pp. 125609-125609
Closed Access | Times Cited: 4
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies
Assem Barakat, Ahmed Mostafa, M. Ali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11861-11861
Open Access | Times Cited: 17
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro
Luiz Saramago, Marcos V. Santana, Bárbara Figueira Gomes, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2866-2880
Closed Access | Times Cited: 10
In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles
Prafullya Kumar Mudi, Rajani Kanta Mahato, Himanshu Verma, et al.
Journal of Molecular Structure (2022) Vol. 1261, pp. 132869-132869
Open Access | Times Cited: 13
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2021) Vol. 21, Iss. 9, pp. 790-818
Closed Access | Times Cited: 16
A benzimidazole scaffold as a promising inhibitor against SARS-CoV-2
Prafullya Kumar Mudi, Ayan Kumar Mahanty, Muddukrishnaiah Kotakonda, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1798-1810
Open Access | Times Cited: 11
Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study
Dmitry S. Kolybalov, E. D. Kadtsyn, Sergey G. Arkhipov
Computation (2024) Vol. 12, Iss. 1, pp. 18-18
Open Access | Times Cited: 2
Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
From Waste to Wealth: Plant-Derived Cellulose Nanocrystal Hydrogel for Anticancer, Antibacterial, and Anticorrosion Studies
Collince Omondi Awere, Valentine Chikaodili Anadebe, Sabapathi Durgadevi, et al.
Carbohydrate Polymer Technologies and Applications (2024), pp. 100656-100656
Open Access | Times Cited: 2
Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study
Kateryna V. Miroshnychenko, Anna V. Shestopalova
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 8672-8686
Open Access | Times Cited: 15
Synthesis, DNA Binding Properties, Molecular Docking and ADME Studies of Schiff Base Compound Containing Pyridine‐Propargyl Group
Seyit Ali Güngör
Chemistry & Biodiversity (2023) Vol. 20, Iss. 11
Closed Access | Times Cited: 6
A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2
Rajani Kanta Mahato, Ayan Kumar Mahanty, Muddukrishnaiah Kotakonda, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
Alexandre de Fátima Cobre, Moisés Maia Neto, Eduardo Borges de Melo, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5881-5894
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top